comparemela.com

Latest Breaking News On - National policy on rare diseases - Page 2 : comparemela.com

Business News | Better Regulatory Mechanism and Patient Registry; a Must for Rare Disease Management; Experts at the IHW Council Rare Disease Summit

Get latest articles and stories on Business at LatestLY. New Delhi [India], July 1: The experts at the Rare Disease Summit emphasised the need for patient registry for accessible treatment opportunities for rare disease patients while deliberating on the various aspects of rare disease management in the country. The summit was organized by the health think tank, Integrated Health and Wellbeing Council in collaboration with AstraZeneca to create awareness on rare diseases and their effective management. Business News | Better Regulatory Mechanism and Patient Registry; a Must for Rare Disease Management; Experts at the IHW Council Rare Disease Summit.

What do you do when your child s life is dependent on a Rs 16 crore drug?

What do you do when your child’s life is dependent on a Rs 16 crore drug? © Provided by The Times of India Ayaansh was about eight months old when his family realised something was wrong he could not crawl or sit up, struggled to have milk or food, and had no neck control. The paediatrician would say that it could be a milestone delay. “But, when he did not achieve any milestone at nine months, we visited a neurologist and were shocked to hear that he had Spinal Muscular Atrophy (SMA),” says Yogesh Gupta, Ayaansh’s father. This was in June 2019. Two years on, the family’s hopes are pinned on a wonder drug - Zolgensma. However, the medicine costs $2.125m (around Rs 16 crore) are prohibitive. So far, the family has been able to raise Rs 1.4 crore and are requesting NGOs, philanthropists and the government to help.

In new rare disease policy, no cover for conditions that cost the most | India News

For Kota-based vegetable vendor and kirana store owner, Mohamad Rafiq, life delivered a nasty punch not once but twice. His first born, a girl by the name of Parveen Nisha, was born with a rare genetic disease called Gaucher’s disease. In this metabolic disease, the patient is born without an enzyme which is responsible for breakdown of fat. In its absence the fat starts accumulating in the liver and spleen, making them grow in size. The child starts to look like a pregnant woman. Parveen could be diagnosed only by the time she turned one-and-a-half and she didn’t survive beyond her 5th birthday because her poor parents couldn’t afford the treatment that costs about Rs 1 crore per year and is life-long. Rafiq’s second born, a son, suffers from the same disease. Now, 4, Rafiq’s son benefitted from free treatment provided by a pharma company for about six months. But his future is uncertain. While the Jaipur high court has ordered a local hospital to foot the bill of his

In new rare disease policy, no cover for conditions that cost the most | Jaipur News

In new rare disease policy, no cover for conditions that cost the most | Jaipur News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Patients with rare diseases seek state intervention- The New Indian Express

Patients with rare diseases seek state intervention  Many patients dealing with rare diseases that need frequent medical attention were affected due to the Covid-19 pandemic. Share Via Email   |  A+A A- By Express News Service KOCHI:  Many patients dealing with rare diseases that need frequent medical attention were affected due to the Covid-19 pandemic. The community that was already struggling to get access to drugs and sustainable funding for treatment is finding it hard to hold on especially children under the age of 10. The delay in finalisation of the National Policy on Rare Diseases is one of the main reasons for this.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.